UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
1. NRx plans to launch HOPE Therapeutics clinics in Fall 2025. 2. Company raised $8.8 million from biotech investors without warrants. 3. HOPE clinics will combine treatments for various cognitive dysfunctions. 4. Matthew Rockefeller joins HOPE Therapeutics Advisory Board to support initiatives. 5. Combined treatments may achieve 90% response rate, potentially increasing demand.